Search research articles
Contact Us
Filters
Showing results (11-20 of 61) with videos related to
Page
of 7
Sort By:
Hepatology (Baltimore, Md.)
|
July 27, 2022
Letter to the editor: Successful treatment of multidrug resistant hepatitis C after >12 months of continuous therapy with direct-acting antivirals
Sheri Trudeau, Vivek Mendiratta, Yara Dababneh, et al.
Scientific Reports
|
November 26, 2020
A genomic signature for accurate classification and prediction of clinical outcomes in cancer patients treated with immune checkpoint blockade immunotherapy
Mei Lu, Kuan-Han Hank Wu, Sheri Trudeau, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 30, 2022
Alcohol-related hepatitis admissions increased 50% in the first months of the COVID-19 pandemic in the USA
Humberto C Gonzalez, Yueren Zhou, Faisal M Nimri, et al.
Carcinogenesis
|
October 16, 2012
Elevated polycyclic aromatic hydrocarbon-DNA adducts in benign prostate and risk of prostate cancer in African Americans
Deliang Tang, Oleksandr N Kryvenko, Yun Wang, et al.
Clinical Epidemiology
|
July 27, 2017
Validity of an automated algorithm using diagnosis and procedure codes to identify decompensated cirrhosis using electronic health records
Mei Lu, Wadih Chacra, David Rabin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 31, 2012
Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancer
Oleksandr N Kryvenko, Michelle Jankowski, Dhananjay A Chitale, et al.
Advances in Therapy
|
April 10, 2024
Correction to: Real-World Safety and Effectiveness of an 8-Week Regimen of Glecaprevir/Pibrentasvir in Patients with Hepatitis C and Cirrhosis
Mei Lu, Loralee B Rupp, Christina Melkonian, et al.
Advances in Therapy
|
January 3, 2024
Real-World Safety and Effectiveness of an 8-Week Regimen of Glecaprevir/Pibrentasvir in Patients with Hepatitis C and Cirrhosis
Mei Lu, Loralee B Rupp, Christina Melkonian, et al.
Hepatology International
|
July 28, 2023
Alcohol-related hepatitis admissions decline in 2021 after a 2020 surge attributed to the COVID-19 pandemic
Humberto C Gonzalez, Faisal M Nimri, Mei Lu, et al.
BMJ Open Gastroenterology
|
October 15, 2020
Normal alkaline phosphatase levels are dependent on race/ethnicity: NationalGEP Health and Nutrition Examination Survey data
Humberto Gonzalez, Zaid Imam, Robert Wong, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 61) with videos related to
Sort By:
Page
of 7
Hepatology (Baltimore, Md.)
|
July 27, 2022
Letter to the editor: Successful treatment of multidrug resistant hepatitis C after >12 months of continuous therapy with direct-acting antivirals
Sheri Trudeau, Vivek Mendiratta, Yara Dababneh, et al.
Scientific Reports
|
November 26, 2020
A genomic signature for accurate classification and prediction of clinical outcomes in cancer patients treated with immune checkpoint blockade immunotherapy
Mei Lu, Kuan-Han Hank Wu, Sheri Trudeau, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 30, 2022
Alcohol-related hepatitis admissions increased 50% in the first months of the COVID-19 pandemic in the USA
Humberto C Gonzalez, Yueren Zhou, Faisal M Nimri, et al.
Carcinogenesis
|
October 16, 2012
Elevated polycyclic aromatic hydrocarbon-DNA adducts in benign prostate and risk of prostate cancer in African Americans
Deliang Tang, Oleksandr N Kryvenko, Yun Wang, et al.
Clinical Epidemiology
|
July 27, 2017
Validity of an automated algorithm using diagnosis and procedure codes to identify decompensated cirrhosis using electronic health records
Mei Lu, Wadih Chacra, David Rabin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 31, 2012
Inflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancer
Oleksandr N Kryvenko, Michelle Jankowski, Dhananjay A Chitale, et al.
Advances in Therapy
|
April 10, 2024
Correction to: Real-World Safety and Effectiveness of an 8-Week Regimen of Glecaprevir/Pibrentasvir in Patients with Hepatitis C and Cirrhosis
Mei Lu, Loralee B Rupp, Christina Melkonian, et al.
Advances in Therapy
|
January 3, 2024
Real-World Safety and Effectiveness of an 8-Week Regimen of Glecaprevir/Pibrentasvir in Patients with Hepatitis C and Cirrhosis
Mei Lu, Loralee B Rupp, Christina Melkonian, et al.
Hepatology International
|
July 28, 2023
Alcohol-related hepatitis admissions decline in 2021 after a 2020 surge attributed to the COVID-19 pandemic
Humberto C Gonzalez, Faisal M Nimri, Mei Lu, et al.
BMJ Open Gastroenterology
|
October 15, 2020
Normal alkaline phosphatase levels are dependent on race/ethnicity: NationalGEP Health and Nutrition Examination Survey data
Humberto Gonzalez, Zaid Imam, Robert Wong, et al.
Page
of 7